You can now download and read the touching and impactful summary of input from GM1 gangliosidosis caregivers and family given during the October 2022 GM1 Externally-led patient-focused drug development meeting with the FDA (EL-PFDD).
The GM1 Gangliosidosis Voice of the Patient Report
You can also view the report on the FDA’s website.